Background Severe acute respiratory syndrome (SARS) is a condition of unknown cause
that has recently been recognized in patients in Asia, North America, and Europe. This report …

Background Cryptococcal meningitis accounts for more than 100,000 human immunodeficiency
virus (HIV)–related deaths per year. We tested two treatment strategies that could be …

Importance Nursing home residents have been disproportionately affected by coronavirus
disease 2019 (COVID-19). Prevention recommendations emphasize frequent testing of health …

In the course of examining epitope-specific CTL responses to intramuscular plasmid DNA
immunization with influenza nucleoprotein (NP)-expressing vectors, a nonimmunogenic …

Background To date, only monoclonal antibodies have been shown to be effective for
outpatients with COVID-19. Interferon lambda-1 is a type III interferon involved in innate antiviral …

Background Cryptococcal meningitis associated with human immunodeficiency virus (HIV)
infection causes more than 600,000 deaths each year worldwide. Treatment has changed …

Methods After research ethics board approval and informed consent, two researchers used
a structured questionnaire to interview quarantined healthcare workers. The questionnaire …

Background Limited data are available on the prevalence and predictors of clinical sequelae
in survivors of Ebola virus disease (EVD). The EVD Survivor Clinic in Port Loko, Sierra …

Background Previous studies have reported an extremely unbalanced global access to opioid
analgesics. We aimed to determine contemporary trends and patterns of opioid analgesic …

Objective To determine if inhaled and intranasal ciclesonide are superior to placebo at
decreasing respiratory symptoms in adult outpatients with covid-19. Design Randomised, double …